Zanca A - Search Results

1

'In vitro' study of chemotherapeutic activity of sulphimidazole on some sensitive and metronidazole-resistant Trichomonas vaginalis strains.

Malagoli M, Rossi T, Baggio A, Zandomeneghi G, Zanca A, Casolari C, Castelli M. Malagoli M, et al. Among authors: zanca a. Pharmacol Res. 2002 Nov;46(5):469-72. doi: 10.1016/s1043661802002074. Pharmacol Res. 2002. PMID: 12419652

2

Interaction between saquinavir and antimycotic drugs on C. albicans and C. neoformans strains.

Casolari C, Rossi T, Baggio G, Coppi A, Zandomeneghi G, Ruberto AI, Farina C, Fabio G, Zanca A, Castelli M. Casolari C, et al. Among authors: zanca a. Pharmacol Res. 2004 Dec;50(6):605-10. doi: 10.1016/j.phrs.2004.06.008. Pharmacol Res. 2004. PMID: 15501699

3

Cytotoxicity and probable mechanism of action of sulphimidazole.

Castelli M, Malagoli M, Lupo L, Roffia S, Paolucci F, Cermelli C, Zanca A, Baggio G. Castelli M, et al. Among authors: zanca a. J Antimicrob Chemother. 2000 Oct;46(4):541-50. doi: 10.1093/jac/46.4.541. J Antimicrob Chemother. 2000. PMID: 11020250

4

Antiviral and antiproliferative activity in vitro of some new benzimidazole derivatives.

Castelli M, Malagoli M, Lupo L, Riccomi TR, Casolari C, Cermelli C, Zanca A, Baggio G. Castelli M, et al. Among authors: zanca a. Pharmacol Toxicol. 2001 Feb;88(2):67-74. Pharmacol Toxicol. 2001. PMID: 11169164

5

Griseofulvin-methisoprinol combination in the treatment of herpes zoster.

Castelli M, Zanca A, Giubertoni G, Zanca A, Bertolini A. Castelli M, et al. Among authors: zanca a. Pharmacol Res Commun. 1986 Oct;18(10):991-6. doi: 10.1016/0031-6989(86)90101-3. Pharmacol Res Commun. 1986. PMID: 2433701 Clinical Trial.

6

Preliminary results of a clinical trial relative to the use of rifamycin SV in the treatment of herpes zoster.

Bruni L, Califano A, De Angelis G, Montagnani A, Pisani M, Pezzarossa G, Pozzo G, Reali D, Rebora A, Zanca A. Bruni L, et al. Among authors: zanca a. J Int Med Res. 1980;8(1):1-6. doi: 10.1177/030006058000800101. J Int Med Res. 1980. PMID: 6987112 Clinical Trial.

7

[Rifamycin SV in the treatment of herpes zoster. Results of a multicenter clinical investigation].

Bruni L, Califano A, De Angelis G, Montagnani A, Pisani M, Pezzarossa G, Pozzo G, Reali D, Rebora A, Zanca A. Bruni L, et al. Among authors: zanca a. G Ital Dermatol Venereol. 1984 Nov-Dec;119(6):XXIII-VII. G Ital Dermatol Venereol. 1984. PMID: 6397429 Clinical Trial. Italian. No abstract available.

8

Pre-surgical basal cell carcinoma margin definition: the SMART approach.

Gualdi G, Venturini M, Zanca A, Calzavara-Pinton PG, Pellacani G. Gualdi G, et al. Among authors: zanca a. J Eur Acad Dermatol Venereol. 2016 Mar;30(3):474-6. doi: 10.1111/jdv.12858. Epub 2014 Nov 21. J Eur Acad Dermatol Venereol. 2016. PMID: 25413728 No abstract available.

9

A new approach for presurgical margin assessment by reflectance confocal microscopy of basal cell carcinoma.

Venturini M, Gualdi G, Zanca A, Lorenzi L, Pellacani G, Calzavara-Pinton PG. Venturini M, et al. Among authors: zanca a. Br J Dermatol. 2016 Feb;174(2):380-5. doi: 10.1111/bjd.14244. Epub 2015 Dec 12. Br J Dermatol. 2016. PMID: 26498991

10

Prevalence and risk factors of actinic keratosis in patients attending Italian dermatology clinics.

Fargnoli MC, Altomare G, Benati E, Borgia F, Broganelli P, Carbone A, Chimenti S, Donato S, Girolomoni G, Micali G, Moggio E, Parodi A, Piaserico S, Pistone G, Potenza C, Puviani M, Raucci M, Vaccari S, Veglio S, Zanca A, Peris K. Fargnoli MC, et al. Among authors: zanca a. Eur J Dermatol. 2017 Dec 1;27(6):599-608. doi: 10.1684/ejd.2017.3126. Eur J Dermatol. 2017. PMID: 29311040 English.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

90 results

Search Page